PRESS RELEASE – A hug against cancer

Defeating cancer with a hug is possible. It’s science suggesting it, in an article published in the prestigious international journal Nucleic Acids Research. Scientists observed that the “embrace” between the antitumor molecule Actinomicin D (ActD) with some structures of our DNA can inhibit the activity of enzymes linked to the replication of cancer cells through a stabilizing action, providing valuable information for the development of new treatments.

The discovery is the result of the work of a group of researchers from the University of Perugia and the Institute of Materials of the National Research Council (IOM-CNR), as part of an international collaboration. It provides useful data for the development of drugs directly targeting the diseased cells, thus reducing the need to resort to chemotherapy.

The research group studied the interaction of the ActD molecule with G-quadruplex – structures of quadruple helix DNA rich in guanine (base nitrogen which, together with thymine, adenine and cytosine, makes up the DNA) located in different points of the chromosomes and, in particular, in their terminal parts, the telomeres. These regions are particularly critical because they predispose the creation of telomerase, a fundamental enzyme for cell growth and replication, which disappears in almost all cells, once embryonic development is complete. Its reactivation at a later stage, and therefore its intervention for indefinite times in the composition of telomeres can instead be the cause of the generation of a tumour.

The formation of quadruplex, however, is able to switch off the telomerase functionality. The aim of the research coordinated by Alessandro Paciaroni and Lucia Comez was to find a way to stabilize the G-quadruplex of the terminal regions of the chromosomes, in order to inhibit the action of the telomerase and interrupt the process of uncontrolled proliferation of the tumour cells.

To achieve this, the ActD binding molecule, which is already deployed in some drugs to treat cancer, was used. The combination of different techniques available at the laboratories of the European research infrastructures consortium – CERIC-ERIC, at the ​​Heinz Maier-Leibnitz Zentrum (MLZ) in Munich, at the Jülich Centre for Neutron Science (JNCS) in Jülich and at Elettra Sincrotrone Trieste, has provided information on the way this molecule works, towards promising results.

G-quadruplexs are arranged on overlapping squared bases – generally three, in sequence. It has been observed that ActD – which appears in the form of a plate with two arms – in the interaction with the G-quadruplex places on it, putting the arms respectively above and below the structure, as in an embrace. This bond produces a chemical reaction that leads to stabilizing the G-quadruplex through their dimerization, i.e. the chemical process by which two molecules of the same compound meet in a double entity, making it more stable. The stabilized structures inhibit the telomerase, blocking the process of tumour formation.

The options for further research development include a deepening of the knowledge of this molecular “embrace”, and the exploration of the possibilities to change the nature of the ActD molecule’s arms, to observe the behaviour and verify its effectiveness. Another field of investigation aims to find out how to bind ActD directly to DNA, or to study the interaction of G-quadruplex with another molecule that is specific to the telomere.

Interaction between G-quadruplex and ActD. The ActD molecule induces a partial dimerization of the G-quadruplex structures favouring their stabilization.

From the press:

For further information, please contact:
Nicoletta Carboni[1]
CERIC Press Office
+39 040 3758953


  1. ^ Nicoletta Carboni (

Source URL: Read More
The public content above was dynamically discovered – by graded relevancy to this site’s keyword domain name. Such discovery was by systematic attempts to filter for “Creative Commons“ re-use licensing and/or by Press Release distributions. “Source URL” states the content’s owner and/or publisher. When possible, this site references the content above to generate its value-add, the dynamic sentimental analysis below, which allows us to research global sentiments across a multitude of topics related to this site’s specific keyword domain name. Additionally, when possible, this site references the content above to provide on-demand (multilingual) translations and/or to power its “Read Article to Me” feature, which reads the content aloud to visitors. Where applicable, this site also auto-generates a “References” section, which appends the content above by listing all mentioned links. Views expressed in the content above are solely those of the author(s). We do not endorse, offer to sell, promote, recommend, or, otherwise, make any statement about the content above. We reference the content above for your “reading” entertainment purposes only. Review “DMCA & Terms”, at the bottom of this site, for terms of your access and use as well as for applicable DMCA take-down request.

Acquire this Domain
You can acquire this site’s domain name! We have nurtured its online marketing value by systematically curating this site by the domain’s relevant keywords. Explore our content network – you can advertise on each or rent vs. buy the domain. | Skype: TLDtraders | +1 (475) BUY-NAME (289 – 6263). Thousands search by this site’s exact keyword domain name! Most are sent here because search engines often love the keyword. This domain can be your 24/7 lead generator! If you own it, you could capture a large amount of online traffic for your niche. Stop wasting money on ads. Instead, buy this domain to gain a long-term marketing asset. If you can’t afford to buy then you can rent the domain.

About Us
We are Internet Investors, Developers, and Franchisers – operating a content network of several thousand sites while federating 100+ eCommerce and SaaS startups. With our proprietary “inverted incubation” model, we leverage a portfolio of $100M in valued domains to impact online trends, traffic, and transactions. We use robotic process automation, machine learning, and other proprietary approaches to power our content network. Contact us to learn how we can help you with your online marketing and/or site maintenance.